Iguana Healthcare Management’s AnaptysBio ANAB Stock Holding History

Iguana Healthcare Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$3.38M	Sell	32,500 -7,500	-19%	-$845K	2.23%	12
2017 Q4	$4.03M	Sell	40,000 -10,000	-20%	-$736K	2.62%	13
2017 Q3	$1.75M	Sell	50,000 -20,000	-29%	-$539K	0.95%	37
2017 Q2	$1.68M	Buy	70,000 +20,000	+40%	+$503K	0.95%	40
2017 Q1	$1.39M	Buy	+50,000	New	+$1.16M	0.69%	45

Other funds holding ANAB

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Iguana Healthcare Management's ANAB Position: Q1 2018 in Review

Iguana Healthcare Management reduced its AnaptysBio (ANAB) stake by 19% in Q1 2018, selling an estimated $845K and leaving 32,500 shares worth $3.38M. The position accounts for 2.23% of the portfolio, ranked #12.

Iguana Healthcare Management first reported a position in ANAB in Q1 2017 and has held it in 5 quarters since. The position peaked at $4.03M in Q4 2017. 134 funds tracked by Wall St. Rank hold ANAB as of Q1 2018.

Iguana Healthcare Management held 32,500 shares of AnaptysBio worth $3.38M as of Q1 2018.
Iguana Healthcare Management sold 7,500 AnaptysBio shares in Q1 2018, an estimated $845K.
AnaptysBio made up 2.23% of Iguana Healthcare Management's portfolio in Q1 2018, its #12 holding.
Iguana Healthcare Management first reported a position in AnaptysBio in Q1 2017 and has held it in 5 quarters since.
Iguana Healthcare Management's AnaptysBio position peaked at $4.03M in Q4 2017.
134 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.